Windtree Therapeutics Inc.

13F holders, Q2 2024 (June 30)
1holders −8
0new positions
10sold out
$0.00avg. 13F price*

At the end of Q2 2024, 1 institutions reported holding Windtree Therapeutics Inc. in their 13F filings, down 8 from Q1 2024. 0 opened new positions and 10 sold out. The largest holder was IFP Advisors, Inc ($0).

Company
Windtree Therapeutics Inc.
CUSIP
97382D402
Latest filing quarter
Q2 2024

History

Number of 13F holders

0246810 Q1 2024: 9Q1 2024Q2 2024: 1Q2 2024

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions0$0
Exits10$239K

All 13F filers, Q1 2024 → Q2 2024: 674,612 shares sold, net −674,612 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 1 holders

IFP Advisors, Inc 0.00% No change 1 $0

"% of holder's portfolio" is WINDTREE THERAPEUTICS INC's weight in each manager's 13F, not the share of Windtree Therapeutics Inc. the manager owns.